PRIMARY STUDY

The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective

Key Findings:  Targeting the CB1 and CB1 receptors, the symptomatic and therapeutic effects of cannabis, such as decreased gut motility, secretions, and reduced inflammatory edema, may help in inflammatory bowel disorders. But because of the small sample sizes, it is difficult to draw firm conclusions about the safety and efficacy. Larger and better-controlled sample sizes and standardized compositions of cannabis products are needed.

Type of Study:  Meta-analysis

Study Result:  Positive

Research Location(s):  Pakistan, United Kingdom, United States

Year of Pub:  2024


Cannabinoids Studied:  Cannabinoid (unspecified), Endocannabinoid (unspecified)

Phytocannabinoid Source:  Not Applicable

Receptors Studied:  CB1, CB2, GPCR




Citation:  Rauf A, Nisar M, Shaeel M, Athar A, Rehman MMU, Faheem F. The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective. Cureus. 2024 Oct 8;16(10):e71068. doi: 10.7759/cureus.71068. PMID: 39624503; PMCID: PMC11610528.